Disclosed are methods for inhibiting TNFalpha expression, IL-1beta expression, iNOS expression, and NF-kappaB activity and methods for treating autoimmune disease, cancer, or atherosclerosis with a compound of the following formula:
申请公布号
US2009131427(A1)
申请公布日期
2009.05.21
申请号
US20080335902
申请日期
2008.12.16
申请人
HUTCHISON MEDIPHARMA ENTERPRISES LIMITED
发明人
SU WEIGUO;JIA HONG;ZHANG WEIHAN;YAN XIAOQIANG;DUAN JIFENG;WANG TAO;CAI YU
